Legislation

Title: Investigational Drugs, Biological Products, and Devices - Right to Try Act
Sponsored by: Delegate K. Young
Status: In the House - Withdrawn by Sponsor
Analysis: Fiscal and Policy Note

Synopsis

Authorizing a manufacturer of an investigational drug, biological product, or device to make available the investigational drug, biological product, or device to eligible patients; specifying the manner in which a specified drug, product, or device may be provided to eligible patients; prohibiting a health occupations board from taking specified action against a health care provider's license on a specified basis; establishing that this Act does not create a specified cause of action; etc.

Committees

Original:: Health and Government Operations Click to view Recorded Media

Details

Cross-filed with: SB0063

Bill File Type: Pre-Filed

Effective Date(s): October 1, 2016

History

Legislation History
Chamber House Calendar Date 12/16/2015 Legislative Date 6/02/2015 Action Pre-filed Proceedings
Chamber House Calendar Date 12/16/2015 Legislative Date 1/13/2016 Action First Reading Health and Government Operations Proceedings
Chamber House Calendar Date 1/13/2016 Legislative Date 1/13/2016 Action Hearing 1/28 at 1:00 p.m. Proceedings
Chamber House Calendar Date 3/11/2016 Legislative Date 3/15/2016 Action Unfavorable Report by Health and Government Operations; Withdrawn Proceedings

Chamber	Calendar Date	Legislative Date	Action
House	12/16/2015	6/02/2015	Pre-filed
House	12/16/2015	1/13/2016	First Reading Health and Government Operations
House	1/13/2016	1/13/2016	Hearing 1/28 at 1:00 p.m.
House	3/11/2016	3/15/2016	Unfavorable Report by Health and Government Operations; Withdrawn

Documents

Date Posted	Document Name
12/17/2015	Text - First - Investigational Drugs, Biological Products, and Devices - Right to Try Act
3/15/2016	Vote - House - Committee - Health and Government Operations

File Code

Subjects

Statutes